Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy

Journal of the American College of Cardiology

Volumn 40, Issue 6, 2002, Pages 1140-1150

  Saksena, Sanjeev ^a   Prakash, Atul ^a   Ziegler, Paul ^g   Hummel, John D ^b   Friedman, Paul ^c   Plumb, Vance J ^d   Wyse, D George ^e   Johnson, Eric ^f   Fitts, Stephanie ^g   Mehra, Rahul ^g  

^a Atlantic Health   (United States)

^b MidOhio Cardiology and Vascular Consultants   (United States)

^c MAYO CLINIC   (United States)

^d Department of Medicine   (United States)

^e UNIVERSITY OF CALGARY   (Canada)

^f The Stern Cardiovascular Center   (United States)

^g MEDTRONIC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART RHYTHM; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SAFETY; SURVIVAL; TREATMENT OUTCOME;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; BRADYCARDIA; CARDIAC PACING, ARTIFICIAL; COMBINED MODALITY THERAPY; CROSS-OVER STUDIES; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; TIME FACTORS;

EID: 0037130761     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02068-5     Document Type: Article

References (21)

1. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study
2. Prevention of symptomatic recurrences in patients with paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy: A multicenter double blind crossover study of flecainide and placebo with transtelephonic monitoring
3. Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter
4. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. The atrial pacing peri-ablation for paroxysmal atrial fibrillation (PA (3)) study investigators
5. Long-term follow-up of patients from a randomized trial of atrial versus ventrlcular pacing for sick-sinus syndrome
6. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes
7. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing
8. Atrial tachyarrhythmias associated with high degree interatrial conduction block: Prevention by permanent atrial resynchronization
9. Regional right and left atrial activation patterns during single and dual-site atrial pacing in patients with atrial fibrillation
10. Acute effects of dual-site right atrial pacing in patients with spontaneous and inducible atrial flutter and fibrillation
11. Conflict of interest guidelines for a multicenter clinical trial of treatment after coronary artery bypass graft surgery
12. Design and implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) clinical trial
13. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction
14. Amiodarone to prevent atrial fibrillation
15. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single and dual-site right atrial pacing for arrhythmia prevention
16. Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter
17. A new pacing algorithm for overdrive suppression of atrial fibrillation
18. Effects of different atrial pacing modes on atrial electrophysiology: Implicating the mechanism of biatrial pacing in prevention of atrial fibrillation
19. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: Effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol
20. Effects of biatrial pacing in prevention of postoperative atrial fibrillation after coronary bypass surgery
21. Dual-site atrial pacing for prevention of atrial fibrillation (DAPPAF) trial: Echocardiographic evaluation of atrial and ventricular function during a randomized trial of support, high right atrial and dual site right atrial paring